A key brain protein called monoamine oxidase A (MAO-A) – is highly elevated during clinical depression yet is unaffected by treatment with commonly used antidepressants, according to an important study published in the Archives of General Psychiatry. The study has important implications for our understanding of why antidepressants don’t always work…
Popularity: unranked [?]
Related posts:
- Key Target Of Clinical Depression Missed By Most Antidepressants
- Identification Of Potential New Drug Target For Depression
- Winter Blues May Be Explained By Fluctuations In Serotonin Transport
- FDA Warnings About Antidepressants Associated With Lasting, Unintended Changes In Diagnosis And Treatment
- FDA Warnings About Antidepressants Associated With Lasting, Unintended Changes In Diagnosis And Treatment
Comments
No Responses to “Key Target Of Clinical Depression Missed By Most Antidepressants”